Abstract

The number of deaths due to cardiovascular and respiratory diseases is increasing annually. Cardiovascular diseases with high mortality rates, such as strokes, are frequently caused by atrial fibrillation without subjective symptoms. Chronic obstructive pulmonary disease is another condition in which early detection is difficult owing to the slow progression of the disease. Hence, a device that enables the early diagnosis of both diseases is necessary. In our previous study, a sensor for monitoring biological sounds such as vascular and respiratory sounds was developed and a noise reduction method based on semi-supervised convolutive non-negative matrix factorization (SCNMF) was proposed for the noisy environments of users. However, SCNMF attenuated part of the biological sound in addition to the noise. Therefore, this paper proposes a novel noise reduction method that achieves less distortion by imposing orthogonality constraints on the SCNMF. The effectiveness of the proposed method was verified experimentally using the biological sounds of 21 subjects. The experimental results showed an average improvement of 1.4 dB in the signal-to-noise ratio and 2.1 dB in the signal-to-distortion ratio over the conventional method. These results demonstrate the capability of the proposed approach to measure biological sounds even in noisy environments.

Highlights

  • The number of deaths from cardiovascular diseases such as ischemic heart disease, angina pectoris, and arrhythmia is increasing annually worldwide [1]

  • We proposed a noise reduction method based on semi-supervised convolutive non-negative matrix factorization (SCNMF), which is an extension of NMF [24]

  • The signal-to-distortion ratio (SDR) of orthogonality-constrained convolutive NMF (OCNMF) exceeded that of SCNMF for all subjects, with a minimum difference of 0.2 dB and a maximum difference of 5.5 dB

Read more

Summary

Introduction

The number of deaths from cardiovascular diseases such as ischemic heart disease, angina pectoris, and arrhythmia is increasing annually worldwide [1]. Atrial fibrillation is a cardiovascular disease that may cause serious cerebrovascular issues. Atrial fibrillation manifests as an abnormal electrical signal in the atria and causes irregular pulsing and inability to pump sufficient blood [2]. The initial symptoms of atrial fibrillation include abnormalities in the conduction system, such as an irregular pulse. The chronicity of these symptoms can lead to severe cerebral infarction [5,6]. Chronic obstructive pulmonary disease (COPD) is a respiratory disease responsible for an increasing number of deaths

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call